Severe gastrointestinal illness associated with olestra ingestion.
Barlam
Tamar F
TF
McCloud
Eric
E
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D002648:Child; D003082:Colectomy; D005227:Fatty Acids / Q000009:adverse effects*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D019804:Mesalamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013395:Sucrose / Q000009:adverse effects* / Q000031:analogs & derivatives*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000963:Antimetabolites; D005227:Fatty Acids; D019804:Mesalamine; D013395:Sucrose; C013692:sucrose polyester; D015122:Mercaptopurine; D011241:Prednisone